Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Vaxcel Incorporated

Vaxcel, Inc. is engaged in the development and commercialization of vaccine adjuvants and delivery systems and a novel vaccine for the treatment of cancer.


Contact Details:
154 Technology Parkway
Norcross
GA
30092
United States of America
Tel:770 453 0195
Fax:770 453 0194
Email:

Loading...

Recent Publications by Vaxcel Incorporated:

Design and development of adjuvant-active nonionic block copolymers.
Nonionic block copolymers are surfactants synthesized using propylene...
19th July, 2000
Vaxcel, Inc., 154 Technology Parkway, Norcross, Georgia 30092 and CytRx J Pharm Sci. 1998 Nov;87(11):1357-62.
DOI Direct Link

Vaxcel Incorporated Patents:

US Patent No.Title
5857763 Lighting mirror fixture
5843451 Intranasal immunization against viral infection using viral glycoprotein subunit vaccine

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 315 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: vaxcel norcross | 770 453-0195 | .

Search for more companies in Norcross

Search for more companies in GA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Vaxcel Incorporated

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.